| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 29/03/2009 | 23:08 | Dow Jones News | Study Shows Equal Clotting Risk With Coated, Bare Stents | BIT:ABT | Abbott Laboratories |
| 29/03/2009 | 20:10 | Dow Jones News | Heart Doctor Still Likes Odds For 'Good' Cholesterol Drugs | BIT:ABT | Abbott Laboratories |
| 29/03/2009 | 17:44 | Dow Jones News | UPDATE: Abbott: Stent Tops Rival Device In Three-Year Study | BIT:ABT | Abbott Laboratories |
| 29/03/2009 | 16:12 | Dow Jones News | Abbott: Stent Tops Rival Device In Three-Year Study | BIT:ABT | Abbott Laboratories |
| 29/03/2009 | 15:30 | PR Newswire (US) | Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between | BIT:ABT | |
| 28/03/2009 | 19:59 | Dow Jones News | UPDATE: Big Study Shows Coated Stents Topping Older Versions | BIT:ABT | Abbott Laboratories |
| 28/03/2009 | 19:27 | Dow Jones News | UPDATE:Stents Cost Less Than Bypass For Many Patients -Study | BIT:ABT | Abbott Laboratories |
| 28/03/2009 | 13:00 | Dow Jones News | Stents Cost Less Than Bypass For Many Patients -Study | BIT:ABT | Abbott Laboratories |
| 28/03/2009 | 13:00 | Dow Jones News | Big Study Shows Coated Stents Outperforming Older Versions | BIT:ABT | Abbott Laboratories |
| 27/03/2009 | 20:45 | Dow Jones News | Blockbuster Drugs Would Be Compared Under US Proposal | BIT:ABT | Abbott Laboratories |
| 26/03/2009 | 23:46 | Dow Jones News | Stent-Maker Xtent Has Let Nearly All Employees Go | BIT:ABT | Abbott Laboratories |
| 26/03/2009 | 17:51 | Dow Jones News | UPDATE: Regulators Under Fire For Oversight Of Human Trials | BIT:ABT | Abbott Laboratories |
| 24/03/2009 | 18:07 | Dow Jones News | UPDATE:Hospira To Cut 10% Of Work Force In Streamlining Plan | BIT:ABT | Abbott Laboratories |
| 24/03/2009 | 14:00 | Dow Jones News | Abbott Labs Launches Second Leg Of Bioabsorbable-Stent Study | BIT:ABT | Abbott Laboratories |
| 19/03/2009 | 18:05 | Dow Jones News | US Pharmaceutical Sector Retreats With Broader Market | BIT:ABT | Abbott Laboratories |
| 19/03/2009 | 12:30 | Dow Jones News | Xtent Gets European Stent OK, But Still Needs Cash To Sell | BIT:ABT | Abbott Laboratories |
| 16/03/2009 | 20:01 | Dow Jones News | UPDATE: US Drug Sector Rises After Bernanke Comments | BIT:ABT | Abbott Laboratories |
| 16/03/2009 | 19:30 | Dow Jones News | 2nd UPDATE: J&J Bets On New Stent, Taking On Abbott Device | BIT:ABT | Abbott Laboratories |
| 16/03/2009 | 16:38 | Dow Jones News | UPDATE: J&J Bets On New Stent, Will Take On Abbott Device | BIT:ABT | Abbott Laboratories |
| 16/03/2009 | 16:10 | Dow Jones News | Drug Sector Rises As Fed Chief Bernanke's Upbeat On Recession | BIT:ABT | Abbott Laboratories |
| 16/03/2009 | 14:33 | Dow Jones News | J&J Places Bets On New Stent, Will Take On Abbott Device | BIT:ABT | Abbott Laboratories |
| 12/03/2009 | 23:30 | PR Newswire (US) | The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent | BIT:ABT | |
| 12/03/2009 | 07:18 | Dow Jones News | Aurobindo Pharma Gets Tentative US Approval For HIV Treatment | BIT:ABT | Abbott Laboratories |
| 11/03/2009 | 18:26 | Dow Jones News | PHARMA MARKET: Cimzia Is Important Product For UCB | BIT:ABT | Abbott Laboratories |
| 04/03/2009 | 21:35 | PR Newswire (US) | Abbott to Present at Cowen Annual Health Care Conference | BIT:ABT | |
| 26/02/2009 | 22:33 | Dow Jones News | 3rdUPDATE:Abbott, Chevron Among High-Grade Cos Issuing Bonds | BIT:ABT | Abbott Laboratories |
| 26/02/2009 | 21:40 | Dow Jones News | 2ndUPDATE:Abbott, Chevron Among High-Grade Cos Issuing New Bonds | BIT:ABT | Abbott Laboratories |
| 26/02/2009 | 20:25 | Dow Jones News | UPDATE:Abbott, Chevron Among High-Grade Cos Issuing New Bonds | BIT:ABT | Abbott Laboratories |
| 26/02/2009 | 19:04 | Dow Jones News | Abbott, Chevron Among High-Grade Cos. Issuing New Bonds | BIT:ABT | Abbott Laboratories |
| 26/02/2009 | 04:31 | Dow Jones News | Abbott Labs Opens $300 Million Plant In Singapore, Inks R&D Deal | BIT:ABT | Abbott Laboratories |